Article

Creation of a Vascularized Composite Graft with Acellular Dermal Matrix and Hydroxyapatite

Department of Surgery, Washington University in St. Louis, San Luis, Missouri, United States
Plastic and Reconstructive Surgery (Impact Factor: 3.33). 06/2010; 125(6):1661-9. DOI: 10.1097/PRS.0b013e3181d52830
Source: PubMed

ABSTRACT Biomaterials have shown promise as potential substitutes for human tissue. Studies have demonstrated that attachment of a vascularized pedicle to dermal matrix grafts yields tissues that are resilient enough to patch hernia defects in rats. The purpose of this study was to examine the possibility of creating a viable composite graft completely from biomaterials.
Acellular dermal matrix was enveloped around a square wafer of hydroxyapatite bone substitute. This composite graft was inserted into an extraperitoneal pocket overlying the abdominal musculature. In 30 Sprague-Dawley rats, the superficial epigastric arteriovenous pedicle was dissected free and placed within the midportion of the matrix construct on one side of each animal. A second graft was inserted on the opposite side without the addition of a vascularized pedicle. Each animal served as its own control. Animals were divided into three equal groups and euthanized at time points of 30, 60, and 90 days.
Histologic evaluation of specimens was performed using hematoxylin and eosin and trichrome stains. At 30 days, the dermal matrices demonstrated full-thickness cellular infiltration in all specimens. Collagen deposition was significantly greater in the experimental group at every time point. Cellularity was significantly greater in the experimental group at 30 days, but there were no significant differences between groups at 60 or 90 days.
These results suggest that provision of an arteriovenous blood supply to nonbiologic tissue grafts significantly increases collagen deposition and early cellular deposition. Based on these findings, biomaterials may offer an exciting new method for tissue engineering.

0 Followers
 · 
55 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The state-of-the-art of biocomposites and hybrid biomaterials based on calcium orthophosphates that are suitable for biomedical applications is presented in this review. Since these types of biomaterials offer many significant and exciting possibilities for hard tissue regeneration, this subject belongs to a rapidly expanding area of biomedical research. Through successful combinations of the desired properties of matrix materials with those of fillers (in such systems, calcium orthophosphates might play either role), innovative bone graft biomaterials can be designed. Various types of biocomposites and hybrid biomaterials based on calcium orthophosphates, either those already in use or being investigated for biomedical applications, are extensively discussed. Many different formulations, in terms of the material constituents, fabrication technologies, structural and bioactive properties as well as both in vitro and in vivo characteristics, have already been proposed. Among the others, the nanostructurally controlled biocomposites, those containing nanodimensional compounds, biomimetically fabricated formulations with collagen, chitin and/or gelatin as well as various functionally graded structures seem to be the most promising candidates for clinical applications. The specific advantages of using biocomposites and hybrid biomaterials based on calcium orthophosphates in the selected applications are highlighted. As the way from the laboratory to the hospital is a long one, and the prospective biomedical candidates have to meet many different necessities, this review also examines the critical issues and scientific challenges that require further research and development.
    07/2011; 1(1):3-56. DOI:10.4161/biom.1.1.16782